Raf Sciot

40.2k citations
551 papers · 24.7k · 4 hit papers · h-index 81

Impact in

    • Gastrointestinal Tumor Research and Treatment
  • Rheumatology top 0.05%
    • Soft tissue tumor case studies
    • Bone Tumor Diagnosis and Treatments

Papers in

Raf Sciot

541 papers receiving 24.1k citations

Raf Sciot's Hit Papers

KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours 2006 · 655 citations
6550+8+16Years since publication250500750

Peers

Raf Sciot
Comparison fields: 5 of 154
  • Gastroenterology 4.9k
  • Rheumatology 5.0k
  • Pulmonary and Respiratory Medicine 10.3k
  • Neurology 2.9k
  • Oncology 4.4k
Replace Pancras C.W. Hogendoorn with:
Pancras C.W. Hogendoorn Netherlands
Masazumi Tsuneyoshi Japan
Raphael E. Pollock United States
Brian P. Rubin United States
Masashi Fukayama Japan
Yoshinao Oda Japan
Marco A. Pierotti Italy
Silvana Pilotti Italy
Claudio Doglioni Italy
Gregory Y. Lauwers United States
Raf Sciot relative to Pancras C.W. Hogendoorn Netherlands Pancras C.W. Hogendoorn's profile →
Citations per field
00.5×1.5×2.0×
Pancras C.W. Hogendoorn · 1×
Citations per year

Countries citing papers authored by Raf Sciot

Since Specialization
Citations

This map shows the geographic impact of Raf Sciot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raf Sciot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raf Sciot more than expected).

Fields of papers citing papers by Raf Sciot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raf Sciot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raf Sciot. The network helps show where Raf Sciot may publish in the future.

Co-authors

The 25 scholars most cited alongside Raf Sciot, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Raf Sciot Line = papers co-authored together Raf Sciot links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 551 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study
Hit paper breakdown →
2001975
2
Progressive Multifocal Leukoencephalopathy after Natalizumab Therapy for Crohn's Disease
Hit paper breakdown →
2005789
3
KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours
Hit paper breakdown →
2006655
4
Consensus meeting for the management of gastrointestinal stromal tumors
 Report of the GIST Consensus Conference of 20–21 March 2004, under the auspices of ESMO
Hit paper breakdown →
2005558
5 2001433
6 2005398
7 2003374
8 2004362
9 1999316
10
Correlation between clinicopathological features and karyotype in lipomatous tumors. A report of 178 cases from the Chromosomes and Morphology (CHAMP) Collaborative Study Group.
1996270
11 2010269
12 2002261
13 1988248
14 1999228
15 2006227
16 2009227
17 2005222
18 2000217
19 2005214
20 2008206

About Raf Sciot

Raf Sciot is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology, Oncology, Molecular Biology and Gastroenterology, having authored 551 papers that have together received 24.7k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (191 papers), Gastrointestinal Tumor Research and Treatment (80 papers), Bone Tumor Diagnosis and Treatments (56 papers), Soft tissue tumor case studies (55 papers), Cardiac tumors and thrombi (42 papers), Vascular Tumors and Angiosarcomas (40 papers), Neurofibromatosis and Schwannoma Cases (39 papers) and Tumors and Oncological Cases (36 papers). The work is most often cited by research in Gastroenterology (4.9k citations), Rheumatology (5.0k citations), Pulmonary and Respiratory Medicine (10.3k citations), Neurology (2.9k citations) and Oncology (4.4k citations). Raf Sciot has collaborated with scholars based in Belgium, United States and Netherlands. Frequent co-authors include Maria Dêbiec‐Rychter, Paola Dal Cin, Valeer Desmet, Peter Van Eyken, Herman Van den Berghe, Ivo De Wever, M. van Glabbeke, Fredrik Mertens, Nils Mandahl and Jaap Verweij. Their work appears in journals such as Genes Chromosomes and Cancer, Histopathology, Journal of Clinical Oncology, Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact